Do you have a thorough strategy to remain compliant and mitigate risk?

Do you have a thorough strategy to remain compliant and mitigate risk? - Industry Insights | Elsevier

As part of planning pharmacovigilance, every pharmaceutical company must have a solid strategy to screen scientific literature and conference proceedings for adverse events involving their products. Missing an adverse event could lead to serious responses from regulatory authorities.

Download Minimize your risk in pharmacovigilance